首页|血清白细胞介素-33/生长刺激表达基因2蛋白轴水平与肝癌患者术后复发的关系研究

血清白细胞介素-33/生长刺激表达基因2蛋白轴水平与肝癌患者术后复发的关系研究

扫码查看
目的:分析血清白细胞介素33(IL-33)/生长刺激表达基因2蛋白(ST2)轴水平与肝癌患者术后复发的关系。方法:278例肝癌患者按照肝切除术后12个月是否复发分为复发组、未复发组,对比两组术前血清IL-33、ST2水平及临床资料,分析肝癌患者术后复发的影响因素及血清IL-33、ST2水平预测肝癌患者术后复发的价值。结果:复发组术前血清IL-33、ST2水平高于未复发组(P<0。05)。多因素Logistic回归分析发现,影响肝癌患者术后复发的危险因素包括术前血清甲胎蛋白(AFP)水平≥400ng/mL、合并门静脉癌栓、合并淋巴结转移、血清IL-33水平升高、血清ST2水平升高(OR>1,P<0。05);绘制受试者工作特征(ROC)曲线发现,血清IL-33、ST2二者联合检测的AUC最高。结论:血清IL-33/ST2轴水平上调会增加肝癌患者术后复发风险,且血清IL-33、ST2联合检测预测肝癌患者术后复发的净收益更高。
Study on the Relationship between Serum Interleukin-33/Growth Stimulating Expression Gene 2 Protein Axis Level and Postoperative Recurrence in Liver Cancer Patients
Objective:To analyze the relationship between serum interleukin-33/growth stimulating expression gene 2 protein axis level and postoperative recurrence in patients with liver cancer.Methods:278 liver cancer patients who were divided into recurrence group and non-recurrence group according to whether recurrence occurred 12 months after hepatectomy.Preoperative serum IL-33 and ST2 levels,as well as clinical data,were compared between the two groups.The factors that influence postoperative recurrence in liver cancer patients were also analyzed and the usefulness of serum IL-33 and ST2 levels in predicting postoperative recurrence in liver cancer patients.Results:The preoperative serum IL-33 and ST2 levels in recurrence group were higher than those in non-recurrence group(P<0.05).Multivariate Logistic regression analysis showed that,the risk factors affecting postoperative recurrence of HCC patients included preop-erative serum Alpha-fetoprotein(AFP)level ≥400 ng/mL,portal vein tumor thrombus,lymph node metastasis,elevated serum IL-33 level and elevated serum ST2 level(OR>1,P<0.05).The receiver operating characteristic(ROC)curve showed that,the AUC of combined detection of serum IL-33 and ST2 was the highest.Conclusion:The up-regulation of serum IL-33/ST2 axis will increase the risk of post-operative recurrence in liver cancer patients,and the combined detection of serum IL-33 and ST2 predicts a higher net benefit of postop-erative recurrence in liver cancer patients.

Liver cancerInterleukin-33Growth stimulating expression gene 2 proteinRecurrence

胡晓菡、谢安然、王贤、孙武、李淼

展开 >

南京大学医学院附属鼓楼医院检验科 江苏南京 210008

南京大学医学院附属鼓楼医院肿瘤科 江苏南京 210008

肝癌 白细胞介素33 生长刺激表达基因2蛋白 复发

2024

现代生物医学进展
黑龙江省森工总医院 哈尔滨医科大学附属第四医院

现代生物医学进展

CSTPCD
影响因子:0.755
ISSN:1673-6273
年,卷(期):2024.24(24)